Certain factors may increase the likelihood of experiencing bloating on GLP-1 therapy, including: Pre-existing gastrointestinal conditions such as irritable bowel syndrome (IBS), functional dyspepsia, or small intestinal bacterial overgrowth (SIBO) Rapid dose escalation without adequate titration periods Dietary factors , particularly high intake of fermentable carbohydrates (FODMAPs), fatty foods, or carbonated beverages Concurrent medications that affect gastrointestinal motility Patients should be aware that GLP-1 receptor agonists have been associated with more serious gastrointestinal adverse effects, including pancreatitis (inflammation of the pancreas) and gallbladder disease
Eating smaller meals and avoiding fatty foods can help
She is Foundation Chair of Mental Health at Western Sydney University (WSU) and Director for Mental Health Research for the South Western Sydney Local Health District
McDonald ES, Randon KR, Knight A, Windebank AJ
The powdered sugar situation was fully out of control when I looked up and saw Tracy Zvenyach waiting at her gate, right next to mine
You can improve appetite control & suppressants outcomes when you combine any therapy with a reduced calorie eating plan and regular activity